Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

71.06
+1.241.78%
Post-market: 70.50-0.5623-0.79%16:12 EDT
Volume:897.68K
Turnover:63.18M
Market Cap:5.93B
PE:-116.49
High:71.45
Open:69.67
Low:68.02
Close:69.82
52wk High:90.87
52wk Low:48.28
Shares:83.46M
Float Shares:77.19M
Volume Ratio:0.95
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6100
EPS(LYR):7.78
ROE:-7740.12%
ROA:2.46%
PB:-35.86
PE(LYR):9.13

Loading ...

PTC Therapeutics Shareholders Back Board, Pay and Auditor

TIPRANKS
·
Jun 06

PTC Therapeutics Raised to Buy From Hold by Jefferies

Dow Jones
·
May 28

PTC Therapeutics Inc : Jefferies Raises to Buy From Hold; Raises Target Price to $85 From $76

THOMSON REUTERS
·
May 27

PTC Therapeutics EVP, CLO Mark Elliott Boulding disposes 2,812 shares for $202,817.36

Reuters
·
May 20

PTC Therapeutics CEO Makes Head-Turning Insider Stock Move

TIPRANKS
·
May 16

PTC Therapeutics EVP, CLO Mark Elliott Boulding disposes 3,540 shares for $279,257.20

Reuters
·
May 13

PTC Therapeutics publishes corporate presentation on Sephience launch, 2026 guidance

Reuters
·
May 11

PTC Therapeutics (PTCT) Gets a Hold from Citi

TIPRANKS
·
May 10

PTC Therapeutics’ Earnings Call Highlights Sephience Surge

TIPRANKS
·
May 09

PTC Therapeutics Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
May 09

Stock Track | PTC Therapeutics Soars 13.49% Intraday on Strong Q1 Earnings Beat, Raised Guidance and Analyst Upgrades

Stock Track
·
May 08

Morgan Stanley Sticks to Its Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
May 08

TD Cowen Upgrades PTC Therapeutics to Buy From Hold, Adjusts Price Target to $90 From $75

MT Newswires Live
·
May 08

Stock Track | PTC Therapeutics Soars 5.57% on Strong Q1 Earnings Beat and Raised Guidance

Stock Track
·
May 08

PTC Therapeutics reports Q1 EPS (3c) vs. ($10.04) last year

TIPRANKS
·
May 08

PTC Therapeutics raises 2026 revenue view to $1.08B-$1.18B, consensus $990.78M

TIPRANKS
·
May 08

GUIDANCE: (PTCT) PTC Therapeutics Expects Full Year 2026 Total Revenue Range $1.08 Billion to $1.18 Billion

MT Newswires Live
·
May 08

Earnings Flash (PTCT) PTC Therapeutics Posts Q1 Loss $0.03 a Share, vs. FactSet Est of $0.47 Loss

MT Newswires Live
·
May 08

PTC Therapeutics Q1 product revenue rises 47%, raises FY guidance

Reuters
·
May 08

PTC Therapeutics Q1 EPS $(0.03) Beats $(0.48) Estimate, Sales $272.551M Beat $218.805M Estimate

Benzinga Earnings
·
May 08